Olaratumab for STS Disappoints in Phase III

Cancer Discovery - United States
doi 10.1158/2159-8290.cd-nb2019-011
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

UK Technology-Boost Plan Disappoints

Nature
Multidisciplinary
2012English

Phase III :

2009English

New Venues in STS

Social Studies of Science
Philosophy of ScienceSocial SciencesHistory
2016English

Olaratumab in Soft Tissue Sarcoma – Current Status and Future Perspectives

European Journal of Cancer
Cancer ResearchOncology
2018English

Sudden Cardiac Death in Epilepsy Disappoints, but Epileptologists Keep Faith

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
2016English

TIPSTER Phase III Accomplishments

1996English

Using Phase II Data for the Analysis of Phase III Studies: An Application in Rare Diseases

Clinical Trials
MedicinePharmacology
2017English

Religion and STS

Bulletin of Science, Technology and Society
ArtsHumanitiesHistoryInnovationManagement of TechnologyEducationSocial SciencesPhilosophy of Science
1997English

Novel Therapies in Phase II and III Trials for Malignant Pleural Mesothelioma

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy